New Radiomedicine, a Chinese medical isotope diagnosis and treatment company, announced on Tuesday that it has raised RMB116 million (US$16.87 million) in a series B round of financing led by BTG International Asia Limited, a subsidiary of London-listed specialist healthcare company BTG plc. Chinese investment firm Hangzhou Ruizhao and returning investor Ningbo Zhongchao Investment also […]

Chinese Medical Isotope Diagnosis and Treatment Firm Raises $16M Fresh Funds comes originally from China Money Network. All Rights Reserved.